Latest Breaking News

Footay

(68 posts)

8. This is just the first of many conditions

Sun Dec 22, 2024, 09:05 AM

6 hrs ago

Mounjaro was approved in June 2022, and I started on it in August that same year. While it's intended for weight loss for me, and has been very successful, there are a host of additional benefits that are now being studied to expand the use. Sleep apnea is just the first on the list. I know there are currently studies for chronic inflammation, cardiovascular conditions and addictions.

My hope is that as each of these conditions is successfully added to the positive attributes associated with GLP-1, they will more widely covered by insurance and the cost will come down.

I am one of the lucky ones whose insurance has covered it from the beginning.

Edit history

Please sign in to view edit histories.

Recommendations

0 members have recommended this reply (displayed in chronological order):

8 replies

= new reply since forum marked as read

Highlight:

FDA approves weight loss drug Zepbound for sleep apnea [View all] BumRushDaShow Yesterday OP

Semiglutide IowaUnionman Yesterday #1

It's tirzepatide afaik n/t DivByZero Yesterday #2

They don't mention side effects, which I'd like to hear more about. I think I know someone who's using Mounjaro... Hekate 22 hrs ago #3

in general if you lose significant weight, you can improve apnea symptoms. Kali 21 hrs ago #4

Back when I was diagnosed with severe sleep apnea and issued a CPAP... Hekate 20 hrs ago #5

GLP-1 drugs are not novel DenaliDemocrat 14 hrs ago #6

This is the first I've ever heard of a drug for sleep apnea, and I've been on a CPAP for 20 years Hekate 11 hrs ago #7

This is just the first of many conditions Footay 6 hrs ago #8